Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for Exercise Tolerance in Chronic Stable Angina
NCT01549977Phase 2Terminated
- Sponsor
- Takeda
- Start
- Jul 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in angina pectoris, sponsored by Takeda. Started Jul 2012; status: terminated.
02
Drugs
febuxostat
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01549977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549977.